Rawal Smita, Xu Jianing, Chen Xianyan, Hall Daniel B, Ricabal Lazara Cabrera, Young Henry N, Caballero Joshua
College of Pharmacy, University of Georgia, Athens, GA, USA.
Department of Statistics, Franklin College of Arts and Sciences, University of Georgia, Athens, GA, USA.
Am J Health Syst Pharm. 2025 Apr 29;82(9):e431-e437. doi: 10.1093/ajhp/zxae314.
The Medicare Prescription Drug, Improvement, and Modernization Act and Centers for Medicare and Medicaid Services affirmation enabled pharmacists to use Current Procedural Terminology (CPT) codes for documentation and billing of clinical services. Despite legislative support and potential availability of pharmacists' clinical services, a gap may exist between the reported availability and actual prevalence of these services in real-world settings. The objective was to assess the prevalence of selected CPT codes (99605-99607, 98966-989968, and 99211-99215) in documenting and billing potential pharmacists' clinical services using recent available data.
This retrospective study utilized the Merative MarketScan Medicare database from the period January 1, 2016, to December 31, 2020. The dataset included deidentified patient information and CPT codes. Patients with CPT codes for face-to-face medication therapy management (MTM) services (99605-99607), codes for telephonic assessment and management (A/M) services (98966-98968), and/or codes for evaluation and management (E/M) services (99211-99215) were identified from outpatient claims. Descriptive statistics, including prevalence rates, were calculated. This study was approved by an institutional review board and followed STROBE guidelines.
There were claims data for 2,784,629 enrollees from 2016 through 2020. Prevalence rates varied during this period, with lower rates for MTM face-to-face CPT codes (0.06%) and telephonic A/M codes (0.58%), while E/M CPT codes showed higher prevalence rates (87%).
Study findings exhibited a limited adoption rate for MTM CPT codes for billing pharmacists' clinical services. Future research may focus on assessing pharmacists' perceptions and identifying facilitators and barriers to using CPT codes in billing clinical services.
《医疗保险处方药、改进与现代化法案》以及医疗保险和医疗补助服务中心的肯定性举措使药剂师能够使用现行程序编码(CPT)对临床服务进行记录和计费。尽管有立法支持且药剂师临床服务具备潜在可利用性,但在现实环境中,这些服务的报告可利用性与实际流行程度之间可能存在差距。目的是利用最新可得数据评估选定的CPT编码(99605 - 99607、98966 - 98968以及99211 - 99215)在记录和计费潜在药剂师临床服务方面的流行程度。
这项回顾性研究使用了2016年1月1日至2020年12月31日期间的默克多市场扫描医疗保险数据库。该数据集包括去识别化的患者信息和CPT编码。从门诊理赔记录中识别出具有面对面药物治疗管理(MTM)服务CPT编码(99605 - 99607)、电话评估与管理(A/M)服务编码(98966 - 98968)和/或评估与管理(E/M)服务编码(99211 - 99215)的患者。计算了包括流行率在内的描述性统计数据。本研究获得了机构审查委员会的批准,并遵循了STROBE指南。
2016年至2020年期间有2,784,629名参保人的理赔数据。在此期间流行率各不相同,MTM面对面CPT编码的流行率较低(0.06%)且电话A/M编码的流行率为(0.58%),而E/M CPT编码的流行率较高(87%)。
研究结果显示,用于药剂师临床服务计费的MTM CPT编码采用率有限。未来的研究可能集中在评估药剂师的看法以及确定在临床服务计费中使用CPT编码的促进因素和障碍。